US Forces Add Hormone Screening

The US Department of Defence has moved to introduce routine testosterone testing for its service members, a step announced by senior official Erik Hegseth. The policy is framed as a way to ensure that soldiers, sailors and airmen are operating at their "absolute best" by catching hormonal deficiencies before they affect performance. In practice, the screening will be added to existing medical check‑ups and will flag low testosterone levels that can cause fatigue, reduced muscle mass and mood swings – all factors that could compromise mission readiness. Hegseth argues that modern warfare demands not only physical fitness but also optimal endocrine health, and that early intervention can keep troops resilient in high‑stress environments. The move also reflects a broader shift in military medicine towards preventative care, mirroring trends in civilian health where hormone balance is increasingly recognised as a pillar of overall wellbeing. By treating hormonal health as a strategic asset, the armed forces hope to maintain a competitive edge while also improving the long‑term health outcomes for their personnel.

For readers, this policy highlights how health optimisation is becoming a national security issue. It signals that employers, especially in high‑performance sectors, may soon adopt similar screening to safeguard productivity. Understanding the link between hormones and performance can also inform personal health decisions, encouraging proactive checks rather than waiting for symptoms to appear.

Hormonal health directly influences energy, cognition and resilience – qualities essential for combat effectiveness. By identifying deficiencies early, the military can intervene with treatment, reducing injury risk and improving morale. The policy also sets a precedent for other organisations to consider endocrine screening as part of occupational health, potentially reshaping workplace wellness standards worldwide.